- Home
- RJET vs ORIC Comparison
RJET vs ORIC Comparison
Compare RJET & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RJET | ORIC |
|---|---|---|
| Founded | 1982 | 2014 |
| Country | United States | United States |
| Employees | 8400 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 930.0M | 837.3M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | RJET | ORIC |
|---|---|---|
| Price | $20.57 | $8.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $19.73 |
| AVG Volume (30 Days) | 112.1K | ★ 1.2M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 19.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.21 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.37 | $5.51 |
| 52 Week High | $23.88 | $14.93 |
Technical Indicators
Market Signals| Indicator | RJET | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 52.28 | 36.54 |
| Support Level | $16.65 | $7.90 |
| Resistance Level | $21.31 | $11.22 |
| Average True Range (ATR) | 1.79 | 0.44 |
| MACD | -0.13 | -0.07 |
| Stochastic Oscillator | 54.30 | 26.18 |
Price Performance
Historical ComparisonAbout RJET Republic Airways Holdings Inc.
Republic Airways Holdings Inc is a regional airline mainly in North America. The company provides scheduled passenger service through its mainline partnerships with American Airlines, Delta Air Lines, and United Airlines. Republic offers scheduled passenger service on several daily flights to various cities in the United States, Canada, Mexico, and the Caribbean. It exclusively operates the dual-class Embraer E170/175 family of aircraft, and provides its services under the American Eagle, Delta Connection, or United Express brands. The company is organized and operates as one operating and reportable segment: regional airline services.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.